JPRN-UMIN000004146尚未招募未知
The clinical effect of Silodosin for lower urinary tract symptoms after permanent prostate brachytherapy - The effect of Silodosin for LUTS after permanent prostate brachytherapy
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •Patient with allergy against Silodocin. Patient with neurogenic bladder, bladder neck constructure, urethral stenosis, vesical stone, or large bladder diverticulum. Patient with active urinary tract infection. Patient with severe renal dysfunction. Patient with severe liver disease. Patient who is considered to be inapropriate for this study by physisian.
研究者
相似试验
已完成
不适用
Efficacy and safety of silodosin on lower urinary tract symptoms (LUTS) in patients with Parkinson's diseases diseaseParkinson's diseaseJPRN-UMIN000008138Juntendo University School of Medicine100
已完成
4 期
Oral Silodosin on Lower Urinary Tract Symptoms Due to Double-J stent: A Prospectively Randomized Studyurinary symptoms assosciated with indwelling double-J ureteral stentsRenal and Urogenital - Other renal and urogenital disordersACTRN12611000569909Chung Jing Wang45
已完成
4 期
Efficacy of Silodosin on Storage and voiding functions in Patients with Benign Prostatic Hyperplasia: A Prospective Study based on Pressure Flow StudyBenign Prostatic HyperplasiaJPRN-UMIN000019286Department of Urology Nagoya University Graduate School of Medicine100
进行中（未招募）
1 期
A clinical study, which evaluates the effectiveness and the safety of a new medication for prostatic hyperplasia, silodosin, when administered under normal conditions of use in a wide European population.EUCTR2011-000045-20-ESRECORDATI S.p.A
进行中（未招募）
1 期
Effectiveness and safety of silodosin in the treatment of patients with benign prostatic hyperplasia.Benign prostatic hyperplasia.EUCTR2011-000045-20-RORECORDATI S.p.A